AMIX
Autonomix Medical, Inc. Common Stock
There isn't enough reported data to score AMIX yet.
AMIX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
AMIX's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
AMIX PE Valuation
AMIX has no meaningful PE right now: it lost money over the past year.
AMIX Forward outlook
There aren't enough analyst estimates for AMIX to show an outlook.
AMIX Earnings Per Share
AMIX Quarterly Revenue
AMIX's revenue is shrinking: $0 last quarter.
AMIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.5M | -$940K |
| Q1 2026 | -$2.9M | +$5.4M |
| Q4 2025 | -$3M | -$670K |
| Q3 2025 | -$3.8M | -$2.2M |
| Q2 2025 | -$2.6M | -$747K |
| Q1 2025 | -$8.3M | -$6M |
| Q3 2024 | -$1.6M | -$452K |
| Q2 2024 | -$1.9M | -$1.2M |
AMIX has burned cash in almost every quarter: −$13M over the past year, against −$15M the year before.
AMIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +129% | +704K shares |
| 1 year | +744% | +1.1M shares |
AMIX has 1M diluted shares, up 744% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
AMIX Net Leverage
AMIX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AMIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.3 | Neutral |
| Stochastic | 0.3 | Oversold |
AMIX's weekly RSI is 31 (neutral) and its Stochastic is 0 (oversold).
AMIX PE vs Healthcare Sector
AMIX has no meaningful PE right now: it lost money over the past year.
AMIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.61 | 48% below |
| 20 week MA | $4.27 | 68% below |
| 50 week MA | $7.29 | 81% below |
| 100 week MA | $22.5 | 94% below |
AMIX is in a downtrend: it's below all four of its weekly moving averages, and 94% below its 100-week average.
AMIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $2,494.8 | $69.3 | -97% |
| 2025 | $69.3 | $12.1 | -83% |
| 2026 YTD | $12.1 | $1.35 | -89% |
AMIX has finished every year since 2024 lower, and it's down 89% so far in 2026.